Senti Biosciences, Inc., a leading gene circuit company, today announced that it has signed a lease agreement for a property in Alameda, California for the build-out of its wholly-owned cell therapy manufacturing facility.
Curt Herberts is signing on at synthetic biology startup Senti Biosciences as its new chief financial officer and chief business officer. First up on the docket? Figuring out the company's partnering strategy and how to blend it with its corporate strateg